X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CURRENT MEDICINAL CHEMISTRY

期刊標題檢索 CURR MED CHEM 最新評論: Submission success rate: 5.0 Experience sharing: Since the magazine o... (2024-05-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CURRENT MEDICINAL CHEMISTRY]您好,您是該頁面的第 94759 位訪客。

期刊簡介
期刊名稱CURRENT MEDICINAL CHEMISTRY CURRENT MEDICINAL CHEMISTRY
LetPub Score
6.7
51 ratings
Rate

Reputation
7.4

Influence
5.6

Speed
9.2

期刊簡稱CURR MED CHEM
ISSN0929-8673
E-ISSN1875-533X
h-index158
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.600.7590.750
Subject fieldQuartilesRankPercentile
Category: Chemistry
Subcategory: Organic Chemistry
Q124 / 211
Category: Chemistry
Subcategory: Pharmacology
Q156 / 313
Category: Chemistry
Subcategory: Drug Discovery
Q131 / 157
Category: Chemistry
Subcategory: Biochemistry
Q186 / 438
Category: Chemistry
Subcategory: Molecular Medicine
Q248 / 178

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Aims & Scope

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
官方網站http://benthamscience.com/journal/index.php?journalID=cmc
在線稿件提交https://mc04.manuscriptcentral.com/crmc
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域医学
出版國/地區NETHERLANDS
發行頻率月2回刊行
創刊年1994
每年文章數242每年文章數趨勢
黃金OA百分比0.31%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ2134/313
CHEMISTRY, MEDICINALSCIEQ232/72
PHARMACOLOGY & PHARMACYSCIEQ2100/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0929-8673%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 3 Month(s)
競爭力 *來自作者的數據: About 20%
參考鏈接
相關期刊 【CURRENT MEDICINAL CHEMISTRY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1282828
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS571227
    JOURNAL OF BIOLOGICAL CHEMISTRY396013
    NUCLEIC ACIDS RESEARCH338224
    CELL298305
    FASEB JOURNAL267365
    International Journal of Biological Sciences237023
    PLANT SCIENCE228223
    Molecular Cancer216884
    ONCOGENE201036
  •  

    CURRENT MEDICINAL CHEMISTRY CURRENT MEDICINAL CHEMISTRY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [CURRENT MEDICINAL CHEMISTRY] 的評論撰寫評論
作者: 金刚统维


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-21 23:02:12 評論於
Submission success rate: 5.0 Experience sharing: Since the magazine only publishes a few issues each year, the rejection rate is very high. The editor replies to your messages immediately, but seems to be avoiding making a decision. After half a month of waiting, the editor still hasn't handled your submission. When you messaged to withdraw your submission, the editor agreed, but after another half a month, the status remained unchanged, and they couldn't even be bothered to formally reject it. This is how this trashy magazine operates
(0) 讚! | 金刚统维

作者: 金刚统维


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-21 17:21:49 評論於
Very slow
(0) 讚! | 金刚统维

作者: 云纵燕舞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-15 19:11:20 評論於
Have you finally recorded it? How long did the review take?
(0) 讚! | 云纵燕舞

作者: 云纵燕舞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-15 08:49:35 評論於
How long did you spend?
(0) 讚! | 云纵燕舞

作者: 影像科医师


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-04-07 21:01:12 評論於
Our revised article has been accepted with no layout fee. Recently, we have been asked to submit a video, recorded by ourselves, introducing the content and advantages of the article to the magazine for the purpose of enabling more people to understand, disseminate, and reference it
(0) 讚! | 影像科医师

作者: kesnesi


領域: 化学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-01-05 23:09:14 評論於
Last year, the research group submitted a review without any publication fee. Is it a new requirement for CMC to ask for publication fees this year if it is accepted?
(0) 讚! | kesnesi

作者: 李拜天KK


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-14 18:26:52 評論於
5.27 Waiting for editing confirmation
6.7 Waiting for initial review
6.14 Reviewing manuscript
(0) 讚! | 李拜天KK

作者: 李拜天KK


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-07 10:28:02 評論於
Submitted on 5.27, it has been half a month and the status is still awaiting reviewer selection.
(0) 讚! | 李拜天KK

作者: 奉天凡白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-05 09:53:58 評論於
How long did the first repair take?
(0) 讚! | 奉天凡白

作者: 玉萧斐然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-21 20:45:59 評論於
Hello, could you please share the submission process?
(0) 讚! | 玉萧斐然

作者: 无相姝贝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-15 08:09:13 評論於
Review speed: 1.0 | Submission hit rate: 95.0 Experience sharing: just now
(0) 讚! | 无相姝贝

作者: Don


領域:
審稿時間: 0.0 month(s)
結果: 拒稿


撰寫評論

2023-02-07 23:58:06 評論於
It is a bullshit journal. Never submit to it. One of the slowest Journal. You will waste your time. It has been 2 months after acceptance without proof or uncorrected proof. you will only waste your time and repent later if you ever submitted an article to this journal. so be very careful.
(0) 讚! | Don

作者: ha1


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-27 17:54:32 評論於
May I ask how is the progress of your final submission upstairs? I have been waiting for editorial approval for half a month, just like you.
(0) 讚! | ha1

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:07:17 評論於
If conditions allow, try to supplement the experiment as much as possible. If it is really not possible, then seriously consider presenting a reasoned defense, but a humble and cautious tone is essential. After all, major revisions also have a certain rejection rate
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:12:27 評論於
When responding to the comments of the reviewers, all issues must be addressed one by one without omission; try to meet the experimental requirements mentioned in the comments, and provide reasonable reasons if unable to meet the requirements; make sure to cite the literature recommended by the reviewers and discuss it thoroughly; when submitting the revised manuscript, make sure to check the corrections made in the initial draft. When responding to the suggestions of the journal editor, if you agree with the modifications proposed by the editor, you can directly accept the changes. If you disagree, write down your reasons below the comments, and then provide feedback to the editor. In case of disagreement between the two parties, further negotiation will be necessary
(0) 讚! | 维尔娜菲茨杰拉德

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 17:52:35 評論於
What is the difference between responding to reviewers' comments and responding to editorial comments?
(0) 讚! | 修然小公主

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 12:51:57 評論於
The reviewer asked me to supplement the experiment, but my samples have been used up/experiment has ended. Can I be rejected just by saying that my samples have run out?
(0) 讚! | 上清雨真

作者: 岭南玉轩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-17 09:08:49 評論於
So slow, it's been four and a half months and still in the first instance. Urged three times with no result, sigh
(0) 讚! | 岭南玉轩

作者: 咏春承嗣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-09-20 16:57:26 評論於
Review speed: 1.0 | Submission success rate: 50.0
Experience sharing: It's been a month already, and it's still in the status of awaiting reviewer selection. The outlook feels very pessimistic
(0) 讚! | 咏春承嗣

作者: chejinxin123happy@163.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2017-09-20 15:59:29 評論於
has been a month, or awaiting reviewer selection status, the prospect is very pessimistic ah
(0) 讚! | chejinxin123happy@163.com

作者: 东风谷雪松


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-11-17 08:54:12 評論於
Could you please tell me if this journal is mainly for review articles?
(0) 讚! | 东风谷雪松

作者: 月河修文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-08-25 12:18:20 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0
Experience sharing: It's been two months since my first submission, and I don't know how it's going
(0) 讚! | 月河修文

作者: Anonymous


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2016-08-25 10:34:01 評論於
The first time, I don’t know how, it’s been two months...
(0) 讚! | Anonymous

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-05-25 13:06:47 評論於
I would like to inquire about the status of the review process, why is my paper still not under review?
(0) 讚! | 凌霄高洁

作者: 正德可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-01-04 17:57:52 評論於
Submitted on June 20, 2012; revised on November 12, given a week for modifications; sent back on November 19 after changes; accepted by 4 people on January 4, 2013. The first draft review was slow, but thorough
(0) 讚! | 正德可爱吗

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [CURRENT MEDICINAL CHEMISTRY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*